These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24267814)

  • 21. Cycle length characteristics differentiating non-sustained from self-terminating ventricular fibrillation in Brugada syndrome.
    Cismaru G; Brembilla-Perrot B; Pauriah M; Zinzius PY; Sellal JM; Schwartz J; Sadoul N
    Europace; 2013 Sep; 15(9):1313-8. PubMed ID: 23419658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of implantable loop recorders in patients with Brugada syndrome and suspected risk of ventricular arrhythmia.
    Kubala M; Aïssou L; Traullé S; Gugenheim AL; Hermida JS
    Europace; 2012 Jun; 14(6):898-902. PubMed ID: 21979995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant fascicular ventricular tachycardia degenerating into ventricular fibrillation in a patient with early repolarization syndrome].
    Kane A; Defaye P; Jacon P; Mbaye A; Machecourt J
    Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):292-5. PubMed ID: 21665187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
    Andorin A; Gourraud JB; Mansourati J; Fouchard S; le Marec H; Maury P; Mabo P; Hermida JS; Deharo JC; Delasalle B; Esnault S; Sadoul N; Davy JM; Leenhardt A; Klug D; Defaye P; Babuty D; Sacher F; Probst V
    Heart Rhythm; 2017 Aug; 14(8):1147-1154. PubMed ID: 28411139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catheter Ablation of Brugada Syndrome: Importance of Repeated Administration of Ajmaline to Unmask the Entire Epicardial Substrate.
    Krieger K; Steinfurt J; Lenz C; Keweloh B
    JACC Clin Electrophysiol; 2017 Nov; 3(11):1330-1332. PubMed ID: 29759632
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
    Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brugada Syndrome Presenting as Polymorphic Ventricular Tachycardia-Ventricular Fibrillation Lasting 94 Seconds Recorded on an Ambulatory Monitor.
    Russo CR; Welch TD; Sangha RS; Greenberg ML
    JAMA Intern Med; 2015 Dec; 175(12):1951-4. PubMed ID: 26501938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unusual Brugada syndrome case.
    Orem C; Kiriş G; Durmuş I; Kaplan S; Gedikli O; Baykan M; Gökçe M; Celik S
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):383-4. PubMed ID: 18849234
    [No Abstract]   [Full Text] [Related]  

  • 32. [Arrhythmic storm in a patient with Brugada syndrome--an unusual case].
    Yahalom M; Farah R; Torgeman Y
    Harefuah; 2012 Jul; 151(7):393-7, 437, 436. PubMed ID: 23002688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular fibrillation and ventricular tachycardia triggered by late-coupled ventricular extrasystoles in a Brugada syndrome patient.
    Chinushi M; Furushima H; Hosaka Y; Izumi D; Aizawa Y
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):e1-5. PubMed ID: 20345624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular and supraventricular arrhythmias and heart failure in a patient with left ventricular noncompaction and Brugada syndrome.
    Kaźmierczak J; Zielonka J; Peregud-Pogorzelska M; Kiedrowicz R; Wielusiński M
    Cardiol J; 2011; 18(3):310-3. PubMed ID: 21660923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome.
    Govindan M; Batchvarov VN; Raju H; Shanmugam N; Bizrah M; Bastiaenen R; Kiotsekoglou A; Camm J; Behr ER
    Heart; 2010 Dec; 96(23):1904-8. PubMed ID: 20962343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of late potentials by quinidine in a patient with Brugada syndrome.
    Watanabe H; Chinushi M; Osaki A; Okamura K; Izumi D; Komura S; Hosaka Y; Tanabe Y; Furushima H; Washizuka T; Aizawa Y
    J Electrocardiol; 2006 Jan; 39(1):63-6. PubMed ID: 16387054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-terminated ventricular fibrillation and recurrent syncope.
    Konstantino Y; Morello A; Zimetbaum PJ; Josephson ME
    Am J Cardiol; 2011 Feb; 107(4):638-40. PubMed ID: 21295177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near fatal ventricular fibrillation in Brugada syndrome despite presence of an implanted implantable cardioverter defibrillator.
    Belhassen B; Viskin S
    Can J Cardiol; 2014 Nov; 30(11):1460.e3-5. PubMed ID: 25240706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian variations in ST-segment elevation surrounding the spontaneous onset of ventricular fibrillation in Brugada syndrome.
    Kaneko Y; Nakajima T; Ota M; Kurabayashi M
    J Cardiovasc Electrophysiol; 2012 Jun; 23(6):664-5. PubMed ID: 22004590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.